Tango Therapeutics

Tango Therapeutics TNGX Stock

$21.73   -4.315280%
Add to favorites
Market Cap
$3.68B
LOW - HIGH [24H]
$21.63 - $23.05
VOLUME [24H]
$1.74M
P/E Ratio
0
Earnings per share
-$1.32
ISIN
US87583X1090
Price   Prediction

Tango Therapeutics Price Chart

Sorry, that's all we've gotfor now...

Tango Therapeutics (TNGX) stock price today is 21.73 USD on Tech Market Middle (-4.32% on the day). Updated .

Tango Therapeutics TNGX Financial and Trading Overview

Tango Therapeutics stock price 21.73 USD
Previous Close 22.71 USD
Open 22.11 USD
Bid 21.55 USD x 200
Ask 36.82 USD x 200
Day's Range 21.63 - 23.05 USD
52 Week Range 8.3 - 34.39 USD
Volume 1.74M USD
Avg. Volume 3.43M USD
Market Cap 3.68B USD
Beta (5Y Monthly) 1.223
PE Ratio (TTM) N/A
EPS (TTM) -1.32 USD
Forward Dividend & Yield N/A (0%)
Ex-Dividend Date N/A
1y Target Est 47 USD

TNGX Valuation Measures

Enterprise Value 2.74B USD
Trailing P/E N/A
Forward P/E -12.120367
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)
Price/Book (mrq) 3.7510786
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -12.066

Trading Information

Tango Therapeutics Stock Price History

Beta (5Y Monthly) 1.223
52-Week Change 126.42%
S&P500 52-Week Change 8.67%
52 Week High 34.39 USD
52 Week Low 8.3 USD
50-Day Moving Average 23.49 USD
200-Day Moving Average 23.11 USD

TNGX Share Statistics

Avg. Volume (3 month) 3.43M USD
Avg. Daily Volume (10-Days) 2.75M USD
Shares Outstanding 169.46M
Float 143.08M
Short Ratio 10.59
% Held by Insiders 1.18%
% Held by Institutions 127.45%
Shares Short 48.24M
Short % of Float 28.82%
Short % of Shares Outstanding 28.51%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio N/A
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) September 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -22.97%
Return on Equity (ttm) -36.48%

Income Statement

Revenue (ttm) 0 USD
Revenue Per Share (ttm) 0 USD
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) -151764000 USD
EBITDA -226748000 USD
Net Income Avi to Common (ttm) -207998000 USD
Diluted EPS (ttm) -1.38
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 977.5M USD
Total Cash Per Share (mrq) 5.77 USD
Total Debt (mrq) 31.18M USD
Total Debt/Equity (mrq) 3.18 USD
Current Ratio (mrq) 39.448
Book Value Per Share (mrq) 5.793

Cash Flow Statement

Operating Cash Flow (ttm) -150087008 USD
Levered Free Cash Flow (ttm) -80177376 USD

Profile of Tango Therapeutics

Country United States
State MA
City Boston
Address 201 Brookline Avenue
ZIP 02215
Phone 857 320 4900
Website https://www.tangotx.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 137

Tango Therapeutics, Inc., a precision oncology company, focuses on the discovery and development of drugs in defined patient populations with unmet medical need. The company develops methylthioadenosine -cooperative protein arginine methyltransferase 5 (PRMT5) inhibitors, including TNG462, which is in Phase 1/2 clinical trial for treating pancreatic and lung cancer; and TNG456, a brain-penetrant PRMT5 inhibitor for the treatment of glioblastoma. It is developing TNG260, a co-repressor of repressor element-1 silencing transcription inhibitor to reverse the immune evasion effect of serine-threonine kinase (STK) 11 loss-of-function mutations to treat lung cancer. The company was founded in 2017 and is headquartered in Boston, Massachusetts.

Q&A For Tango Therapeutics Stock

What is a current TNGX stock price?

Tango Therapeutics TNGX stock price today per share is 21.73 USD.

How to purchase Tango Therapeutics stock?

You can buy TNGX shares on the Tech Market Middle exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Tango Therapeutics?

The stock symbol or ticker of Tango Therapeutics is TNGX.

Which industry does the Tango Therapeutics company belong to?

The Tango Therapeutics industry is Biotechnology.

How many shares does Tango Therapeutics have in circulation?

The max supply of Tango Therapeutics shares is 169.46M.

What is Tango Therapeutics Price to Earnings Ratio (PE Ratio)?

Tango Therapeutics PE Ratio is now.

What was Tango Therapeutics earnings per share over the trailing 12 months (TTM)?

Tango Therapeutics EPS is -1.32 USD over the trailing 12 months.

Which sector does the Tango Therapeutics company belong to?

The Tango Therapeutics sector is Healthcare.

Tango Therapeutics TNGX included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
us US Tech Composite IXIC US 22617.73 USD —
-5.28
10.6B USD — 22513.01 USD — 23837.76 USD — — 10.6B USD —
us Stlmt ID US Tech Biotechnology NBX US 4000.62 USD —
-1.26
— — 3927.42 USD — 4148.65 USD — — — —
us US Tech Global Market Composite NQGM US 1743.91 USD —
-3.66
— — 1738.23 USD — 1808.43 USD — — — —
us US Tech Biotechnology NBI US 6781.89 USD —
-1.73
— — 6767.31 USD — 6980.47 USD — — — —
us US Tech Health Care IXHC US 1282.67 USD —
-1.79
— — 1279.99 USD — 1317.94 USD — — — —
$1.95T
Total marketcap
$125.13B
Total volume
BTC 57.19%   •   ETH 9.66%
Dominance
Select currency